<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: fecal occult blood</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Colonoscopy screening reduces risk of advanced colorectal cancer, study finds</title>
   	 <description>A new study led by the Perelman School of Medicine at the University of Pennsylvania adds support to current medical recommendations stating that screening colonoscopy substantially reduces an average-risk adult's likelihood of being diagnosed with advanced colorectal cancer (CRC) in either the right or left side of the colon. In recent years, colonoscopy has begun to rapidly replace sigmoidoscopy – a procedure used to detect abnormalities in the rectum and left side of the colon – despite initially limited evidence of its efficacy and higher cost. In the new study, researchers noted an overall 70 percent reduction of advanced CRC diagnoses associated with receiving a screening colonoscopy. The results of the study suggest that colonoscopy has the ability to effectively identify tumors in both the left and right side of the colon before they progress to an advanced stage. The full results of the study appear online in the Annals of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2013-03-colonoscopy-screening-advanced-colorectal-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 04 Mar 2013 17:00:09 EST</pubDate>
	 <guid isPermaLink="false">news281635036</guid>
	 
</item>
<item>
     <title>Inclusion of CTC as HEDIS screening modality could increase colorectal cancer screening compliance</title>
   	 <description>Availability of CT colonography (CTC), commonly known as virtual colonoscopy, is increasing colorectal cancer (CRC) screening rates across military medical facilities. Inclusion of CTC as a Healthcare Effectiveness Data and Information Set (HEDIS)-compliant colorectal cancer (CRC) screening test can potentially raise overall screening rates, according to a study in the January issue of the Journal of the American College of Radiology.</description>
     <link>http://medicalxpress.com/news/2013-01-inclusion-ctc-hedis-screening-modality.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 10 Jan 2013 16:44:36 EST</pubDate>
	 <guid isPermaLink="false">news277058669</guid>
	 
</item>
<item>
     <title>Many physicians recommend unnecessary cancer screening for the old and sick</title>
   	 <description>A significant number of physicians would recommend colorectal cancer screening for elderly patients with a severe illness, according to David Haggstrom from the Richard L. Roudebush VA Medical Center in Indianapolis in the US and his team. Such patients would not benefit from the procedure and, in fact, unnecessary screening may do more harm than good. Their work appears online in the Journal of General Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2012-06-physicians-unnecessary-cancer-screening-sick.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 04 Jun 2012 11:56:07 EST</pubDate>
	 <guid isPermaLink="false">news258029755</guid>
	 
</item>
<item>
     <title>Study finds sigmoidoscopy reduces colorectal cancer rates</title>
   	 <description>Flexible sigmoidoscopy, a screening test for colorectal cancer that is less invasive and has fewer side effects than colonoscopy, is effective in reducing the rates of new cases and deaths due to colorectal cancer, according to research sponsored by the National Cancer Institute, part of the National Institutes of Health. In a study that spanned almost 20 years, researchers found that overall colorectal cancer mortality (deaths) was reduced by 26 percent and incidence (new cases) was reduced by 21 percent as a result of screening with sigmoidoscopy. These results appeared online, ahead of print, on May 21, 2012, in the New England Journal of Medicine, and were presented at Digestive Disease Week, a scientific conference.</description>
     <link>http://medicalxpress.com/news/2012-05-sigmoidoscopy-colorectal-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 21 May 2012 11:20:01 EST</pubDate>
	 <guid isPermaLink="false">news256816559</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/nihstudyfind.jpg" width="90" height="97" />
</item>
<item>
     <title>Study examines adherence to colorectal cancer screening recommendations</title>
   	 <description>Patients for whom colonoscopy was recommended were less likely to complete colorectal cancer screening than those patients for whom fecal occult blood testing (FOBT) was recommended or those patients who were given a choice between FOBT or colonoscopy, according to a study published in the April 9 issue of Archives of Internal Medicine, a JAMA Network publication.</description>
     <link>http://medicalxpress.com/news/2012-04-adherence-colorectal-cancer-screening.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 09 Apr 2012 16:00:03 EST</pubDate>
	 <guid isPermaLink="false">news253189465</guid>
	 
</item>
<item>
     <title>ACP releases new colorectal cancer screening guidance statement</title>
   	 <description>The American College of Physicians (ACP) today issued a new guidance statement for colorectal cancer screening. Colorectal cancer is the second leading cause of cancer-related deaths for men and women in the United States. The guidance statement and a patient summary appear in the March 6 issue of Annals of Internal Medicine, published by ACP.</description>
     <link>http://medicalxpress.com/news/2012-03-acp-colorectal-cancer-screening-guidance.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 05 Mar 2012 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news250174784</guid>
	 
</item>
<item>
     <title>Flexible sigmoidoscopy shown to increase detection of colorectal cancer</title>
   	 <description>Repeated screening by flexible sigmoidoscopy (FSG) increased the detection of colorectal cancer or advanced adenoma in women by one-fourth and in men by one-third, according to a study published Jan. 31 in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2012-01-flexible-sigmoidoscopy-shown-colorectal-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 31 Jan 2012 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news247238049</guid>
	 
</item>
<item>
     <title>Fecal occult blood testing effective in colonoscopy screenings</title>
   	 <description>Fecal immunochemical testing (FIT) is more effective in its health benefits at the same or lower costs compared to guaiac fecal occult blood testing (gFOBT) at all levels of colonoscopy capacity, according to a study published November 9 by the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2011-11-fecal-occult-blood-effective-colonoscopy.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 09 Nov 2011 16:00:03 EST</pubDate>
	 <guid isPermaLink="false">news240062601</guid>
	 
</item>
<item>
     <title>Single flexible sigmoidoscopy screening associated with reduced colorectal cancer</title>
   	 <description>A single flexible sigmoidoscopy screening between the ages of 55-64 years is associated with a lower level of colorectal cancer (CRC) incidence and mortality, according to a study published online August 18 in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2011-08-flexible-sigmoidoscopy-screening-colorectal-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 18 Aug 2011 16:00:03 EST</pubDate>
	 <guid isPermaLink="false">news232895206</guid>
	 
</item>
<item>
     <title>Noninvasive fecal occult blood test effective screen for lower GI tract lesions</title>
   	 <description>The immunochemical fecal occult blood test (iFOBT) is effective for predicting lesions in the lower intestine but not in the upper gastrointestinal (GI) tract, confirms a study in CMAJ (Canadian Medical Association Journal).</description>
     <link>http://medicalxpress.com/news/2011-08-noninvasive-fecal-occult-blood-effective.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 02 Aug 2011 12:40:03 EST</pubDate>
	 <guid isPermaLink="false">news231506756</guid>
	 
</item>
<item>
     <title>Blood test for colon cancer screening beneficial for some seniors, but not for many others</title>
   	 <description>A new study of U.S. veterans ages 70 and older finds that the healthiest get the most benefit from current colon cancer screening methods. However, for many less healthy veterans the burdens of screening may outweigh the benefits.</description>
     <link>http://medicalxpress.com/news/2011-05-blood-colon-cancer-screening-beneficial.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 09 May 2011 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news224177471</guid>
	 
</item>
<item>
     <title>Colorectal cancer screening rates on rise among Medicare beneficiaries due to expansion of coverage</title>
   	 <description>Colorectal cancer screening rates increased for Medicare beneficiaries when coverage was expanded to average-risk individuals, but racial disparities still exist, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).</description>
     <link>http://medicalxpress.com/news/2011-05-colorectal-cancer-screening-medicare-beneficiaries.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 May 2011 13:20:01 EST</pubDate>
	 <guid isPermaLink="false">news223646624</guid>
	 
</item>


</channel>
</rss>
